Literature DB >> 12760818

Progress in the Diagnosis, Prevention, and Treatment of Pertussis.

Flor M. Munoz1, Wendy A. Keitel.   

Abstract

Pertussis ("whooping cough"), caused by the gram- negative pleomorphic bacillus Bordetella pertussis, is a highly contagious, potentially life-threatening respiratory tract illness that has re-emerged worldwide as a cause of substantial morbidity and mortality in infants, children, and adolescents, even in countries with high vaccination rates. Waning immunity after immunization during childhood has been associated with a growing pool of susceptible adolescents and adults who are capable of transmitting pertussis to vulnerable unvaccinated or incompletely vaccinated infants. The use of acellular pertussis vaccine boosters in adolescents has been proposed and is likely to be recommended. Active immunization and improved methods for early diagnosis are key in the management of pertussis, and represent the most rapidly evolving aspects of this disease.

Entities:  

Year:  2003        PMID: 12760818     DOI: 10.1007/s11908-003-0076-9

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  40 in total

1.  The changing age and seasonal profile of pertussis in British Columbia, not Canada.

Authors:  Eleni Galanis; Arlene King; Paul Varughese
Journal:  J Infect Dis       Date:  2002-11-15       Impact factor: 5.226

2.  Recommended childhood and adolescent immunization schedule--United States, 2003.

Authors: 
Journal:  Pediatrics       Date:  2003-01       Impact factor: 7.124

3.  Reoccurrence of culture-positive pertussis in an infant initially treated with azithromycin and steroids.

Authors:  Jordan M Steinberg; Isaac Srugo
Journal:  Arch Pediatr Adolesc Med       Date:  2002-10

Review 4.  Cellular and acellular pertussis vaccines in adults.

Authors:  W A Keitel
Journal:  Clin Infect Dis       Date:  1999-06       Impact factor: 9.079

5.  The changing age and seasonal profile of pertussis in Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Diane MacDonald; Wrency Wu; Carol Shaw; Jane Macnabb; Sylvie Champagne; David M Patrick; Scott A Halperin
Journal:  J Infect Dis       Date:  2002-04-22       Impact factor: 5.226

6.  Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancy.

Authors:  David P Greenberg; Larry K Pickering; Shelly D Senders; Jeffrey D Bissey; Robert A Howard; Mark M Blatter; Keith Reisinger; Michael E Pichichero; Barbara J Howe
Journal:  Pediatrics       Date:  2002-04       Impact factor: 7.124

7.  Pertussis deaths--United States, 2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-07-19       Impact factor: 17.586

8.  Australia's notifiable diseases status, 2000. Annual report of the National Notifiable Diseases Surveillance System.

Authors:  Ming Lin; Paul Roche; Jenean Spencer; Alison Milton; Phil Wright; David Witteveen; Robyn Leader; Angela Merianos; Chris Bunn; Heather Gidding; John Kaldor; Martyn Kirk; Rob Hall; Tony Della-Porta
Journal:  Commun Dis Intell Q Rep       Date:  2002

9.  Use of lidocaine-prilocaine patch to decrease intramuscular injection pain does not adversely affect the antibody response to diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate and hepatitis B vaccines in infants from birth to six months of age.

Authors:  Beth A Halperin; Scott A Halperin; Patrick McGrath; Bruce Smith; Tricia Houston
Journal:  Pediatr Infect Dis J       Date:  2002-05       Impact factor: 2.129

10.  Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999.

Authors:  Terri Hawes Hardwick; Pamela Cassiday; Robbin S Weyant; Kristine M Bisgard; Gary N Sanden
Journal:  Emerg Infect Dis       Date:  2002-01       Impact factor: 6.883

View more
  3 in total

1.  Incidence and Burden of Pertussis Among Infants Less Than 1 Year of Age.

Authors:  Cristina Masseria; Carolyn K Martin; Girishanthy Krishnarajah; Laura K Becker; Ami Buikema; Tina Q Tan
Journal:  Pediatr Infect Dis J       Date:  2017-03       Impact factor: 2.129

2.  The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective study.

Authors:  Catherine Balderston McGuiness; Jerrold Hill; Eileen Fonseca; Gregory Hess; William Hitchcock; Girishanthy Krishnarajah
Journal:  BMC Infect Dis       Date:  2013-01-23       Impact factor: 3.090

3.  The estimated incidence of pertussis in people aged 50 years old in the United States, 2006-2010.

Authors:  Cristina Masseria; Girishanthy Krishnarajah
Journal:  BMC Infect Dis       Date:  2015-11-19       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.